Press Releases

2019 Breast Cancer Screening Test Market Future Growth Rate by Market Current Strategy, Top Most Players, and Regional Segmentation by Forecast to 2024

May 17, 2019

Breast Cancer Screening Test

The primary goal of this Global Breast Cancer Screening Test Market report is to maintain the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Breast Cancer Screening Test market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Breast Cancer Screening Test market is provided in detail in the report.

Get Sample Copy of Breast Cancer Screening Test Market Report @ https://www.industryresearch.co/enquiry/request-sample/14099150

Key Market Trends:

Imaging Test is Expected to Dominate in the Breast Cancer Screening Test Segment

The most commonly used screening test for breast cancer is the imaging test and these imaging tests are considered as the most reliable ones. Mammograms are the most widely used tests to screen breast cancer. Since mammography is the gold standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. This is increasing the global demand for mammography while laboratory and blood tests and other imaging tests are gaining popularity. Digital breast tomosynthesis can increase the diagnostic accuracy of mammography and is used for the assessment of equivocal or suspicious mammography findings. Other modalities, such as ultrasound and contrast-enhanced magnetic resonance imaging (MRI) play an important role in the diagnostics, staging, and follow-up of breast cancer.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America currently dominates the market for breast cancer screening test and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. This can be majorly attributed to the increasing incidence rates of breast cancer and rising awareness among the population for the early detection of cancer. The presence of the developed healthcare infrastructure is expected to propel the market in the United States.

Breast Cancer Screening Test Market Covers Key Players:

  • Allengers Medical Systems Limited
  • Myriad Genetics
  • Agendia BV
  • Armune BioScience Inc.
  • Metabolomic Technologies Inc.
  • Fujifilm Holdings Corporation
  • Biocrates Life Sciences AG
  • Siemens Healthineers
  • Hologic Inc.
  • Quest Diagnostics Incorporated

    Ask for Discount at https://www.industryresearch.co/enquiry/request-discount/14099150

    Geographical Landscape:

    This Report Focuses on the Breast Cancer Screening Test in the Global market, especially in North America, China, Europe, Japan, Southeast Asia, India. This report categorizes the market based on manufacturers, regions, type, and application

    Market Overview:

  • The breast cancer screening test market is expected to register a CAGR of 4.5% over the forecast period. Factors that are responsible for the growth of this market include the increasing awareness about the early detection of breast cancer, the growing incidence of breast cancer, and the increasing government initiatives and support.
  • Early detection of breast cancer can lead to desired outcomes, including increased survival rate, number of treatment options, and improved quality of life. And the rising incidence of breast cancer is helping the market to grow in the forecast period. As per the Breastcancer.org, about one in eight US women (about 12.4%) will develop invasive breast cancer over the course of their lifetime. In 2018, an estimated 266,120 new cases of invasive breast cancer are anticipated to be diagnosed in women only in the United States, along with 63,960 new cases of non-invasive breast cancer. Since there is a rising need for the breast cancer screening test across developing as well as developed nations, the demand for breast cancer screening tests is increasing which is leading to the growth of this market.

    Report Highlights:

    – The report provides a detailed analysis on current and future market trends to identify the investment opportunities

    – Market forecasts till 2024, using estimated market values as the base numbers

    – Key market trends across the business segments, Regions and Countries

    – Key developments and strategies observed in the market

    – Market Dynamics such as Drivers, Restraints, Opportunities and other trends

    – In-depth company profiles of key players and upcoming prominent players

    – Growth prospects among the emerging nations through 2024

    – Breast Cancer Screening Test Market opportunities and recommendations for new investments

    Price Of Report: $ 4250 (SUL)

    Purchase Breast Cancer Screening Test Market Report @ https://www.industryresearch.co/purchase/14099150

    Detailed TOC of Breast Cancer Screening Test Market Research Report 2019 – 2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Iincreasing Awareness about Early Detection of Breast Cancer
    4.2.2 Growing Incidence of Breast Cancer
    4.2.3 Increasing Government Initiatives and Support
    4.3 Market Restraints
    4.3.1 Controversies Related to Mammography
    4.3.2 High Cost of Screening Tests in the Developing Countries
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Test
    5.1.1 Genomic Tests
    5.1.1.1 MammaPrint Test
    5.1.1.2 Breast Cancer Index Test
    5.1.1.3 Mammostrat Test
    5.1.1.4 PAM50 Test
    5.1.1.5 Oncotype DX Test
    5.1.1.6 Other Genomic Tests
    5.1.2 Imaging Test
    5.1.2.1 Mammograms
    5.1.2.2 Ultrasound
    5.1.2.3 MRI
    5.1.2.4 Tomography
    5.1.2.5 Other Imaging Tests
    5.2 Geography
    5.2.1 North America
    5.2.1.1 US
    5.2.1.2 Canada
    5.2.1.3 Mexico
    5.2.2 Europe
    5.2.2.1 Germany
    5.2.2.2 UK
    5.2.2.3 France
    5.2.2.4 Italy
    5.2.2.5 Spain
    5.2.2.6 Rest of Europe
    5.2.3 Asia-Pacific
    5.2.3.1 China
    5.2.3.2 Japan
    5.2.3.3 India
    5.2.3.4 Australia
    5.2.3.5 South Korea
    5.2.3.6 Rest of Asia-Pacific
    5.2.4 Middle East & Africa
    5.2.4.1 GCC
    5.2.4.2 South Africa
    5.2.4.3 Rest of Middle East & Africa
    5.2.5 South America
    5.2.5.1 Brazil
    5.2.5.2 Argentina
    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Allengers Medical Systems Limited
    6.1.2 Myriad Genetics
    6.1.3 Agendia BV
    6.1.4 Armune BioScience Inc.
    6.1.5 Metabolomic Technologies Inc.
    6.1.6 Fujifilm Holdings Corporation
    6.1.7 Biocrates Life Sciences AG
    6.1.8 Siemens Healthineers
    6.1.9 Hologic Inc.
    6.1.10 Quest Diagnostics Incorporated

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Smoke Detectors Market 2019 Global Industry Size, Outlook, Share, Demand, Manufacturers and 2024 Forecast Research’s